CICC, CITIC To Privatize Chinese Biopharma Firm Sinovac Biotech

Login to View

An investor consortium including CICC Qianhai Development (Shenzhen) Fund Management, CITIC M&A Fund Management Co., Ltd., and a number of Chinese bio-industry companies and investment firms, has agreed to privatize NASDAQ-listed Chinese biopharmaceutical products provider Sinovac Biotech Ltd., at the valuation of around US$401.8 million.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in


RELATED NEWS